Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-03-02 @ 4:11 AM
Study NCT ID:
NCT00918203
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2009-06-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
13900
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None